Hormone therapy prescription among physicians in France and Quebec

Menopause

Volumn 11, Issue 1, 2004, Pages 89-97

  Ringa, Virginie ^a   Légaré, France ^b   Dodin, Sylvie ^c   Norton, Joanna ^a   Godin, Gaston ^b   Bréart, Gérard ^a  

^a INSERM   (France)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Hormone therapy; Menopause; Physicians; Prescription

Indexed keywords

HORMONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CLINICAL PRACTICE; CULTURAL FACTOR; EDUCATION PROGRAM; FEMALE; FRANCE; GENDER; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MEDICAL SPECIALIST; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; STANDARD; TEACHING; COMPARATIVE STUDY; DOCTOR PATIENT RELATION; DRUG UTILIZATION; HORMONE SUBSTITUTION; MALE; MANAGEMENT; MIDDLE AGED; PATIENT EDUCATION; QUESTIONNAIRE; SEX RATIO; STATISTICS; UTILIZATION REVIEW;

AGE DISTRIBUTION; DRUG UTILIZATION; FEMALE; FRANCE; GYNECOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS, FAMILY; PRACTICE MANAGEMENT, MEDICAL; QUEBEC; QUESTIONNAIRES; SEX DISTRIBUTION;

EID: 2442672008     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000072202.41124.1B     Document Type: Article

References (39)

1. Oddens BJ, Boulet MJ, Lehert P, Visser AP. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas 1992;15:171-181.
2. Schneider HP. Cross-national study of women's use of hormone therapy (HRT) in Europe. Int J Fertil Womens Med 1997;42:365-375.
3. Ringa V, Jaussent I, Guéguen R, Bréart G. Trends in the use of hormone therapy in eastern France between 1986 and 1993. Eur J Public Health 1999;9:300-305.
4. Ministère de la santé et des services sociaux. Et la santé, ça va? Rapport de l'Enquête Santé Québec 1992. Québec: Institut de la statistique du Québec; 1995.
5. Gouvernement du Québec. Enquête sociale et de sante 1998. Quebec: Institut de la statistique du Québec; 2000.
6. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2001;(1):CD002978.
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
8. Pilon D, Castilloux A.M, Lelorier J. Estrogen replacement therapy: determinants of persistance with treatment. Obstet Gynecol 2001; 97:97-100.
9. Légaré F, Godin G, Guilbert É, Laperrière L, Dodin S. Determinants of the intention to adopt hormone therapy among premenopausal women. Maturitas 2000;34:211-218.
10. Serfaty D, de Reilhac P, Eschwege E, et al. Compliance with hormone therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy [in French]. Gynecol Obstet Fertil 2003;31: 525-533.
11. Fauconnier A, Ringa V, Delanoë D, Falissard B., Bréart G. Use of hormone therapy: women's representations of menopause and beauty care practices. Maturitas 2000;35:215-228.
12. Clark HD, O'Connor AM, Graham ID, Wells G. What factors are associated with a woman's decision to take hormone therapy? Evaluated in the context of a decision aid. Health Expect 2003;6: 110-117.
13. Marmoreo J, Brown JB, Batty HR, Cummings S, Powell M. Hormone therapy: determinants of women's decisions. Patient Educ Couns 1998;33:289-298.
14. Gallagher TC, Geling O, Comite F. Use of multiple providers for regular care and women's receipt of hormone therapy counseling. Med Care 2001;39:1086-1096.
15. Lancaster T, Surman G, Lawrence M, et al. Hormone therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health 1995;49:349-394.
16. Seto TB, Taira DA, Davis RB, Safran C, Phillips RS. Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 1996;11:197-203.
17. Exline JL, Siegler IC, Bastian LA. Differences in providers' beliefs about benefits and risks of hormone therapy in managed care. J Womens Health 1998;7:879-884.
18. Nilsen ST, Pedersen AT, Moen MH, et al. Knowledge, attitudes and management strategies in Scandinavia concerning hormone therapy: a comparison between gynecologists in Denmark, Norway and Sweden. Maturitas 2001;39:83-90.
19. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: Wiley-Interscience; 1978.
20. Suarez-Almazor M, Homik JE, Messina D, Davis P. Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis; J Bone Min Res 1997;12: 1100-1107.
21. Rozenberg S, Vasquez JB. Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists. Maturitas 2000;35:125-128.
22. Nikolajevic-Sarunac J, Henry DA, O'Connell DL, Robertson J. Effects of information framing on the intentions of family physicians to prescribe long-term hormone therapy. J Gen Intern Med 1999; 14:591-598.
23. Fivaz C. Les gynécologues libéraux en 1997. Direction des statistiques et des études. Point Stat 1999;23:1-8.
24. Massé R, Légaré F, Côté LD, Dodin S. The limitations of a negotiation model for perimenopausal women. Social Health Illn 2001; 23:44-64.
25. Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone therapy by women doctors. Br Med J 1995;311:1399-1401.
26. Isaacs AJ, Britton AR, McPherson K. Why do women doctors in the UK take hormone therapy? J Epidemiol Community Health 1997; 51:373-377.
27. Jolleys JV, Olesen F. A comparative study of prescribing of hormone therapy in USA and Europe. Maturitas 1996;23:47-53.
28. A physician Human Resource. Strategy for Canada. Centre Syndical et patronal du Canada. Task Force two http://www. physicianhr.ca/reports/ literatureReviewGapAnalysis-f.pdf. Accessed November 14, 2003.
29. Stafford, R.S. Saglam, D. Causino, N. Blumenthal, D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol 1997;177:381-387.
30. Ringa V, Ledesert B, Gueguen R, Schiele F, Bréart G. Determinants of hormonal replacement therapy in recently postmenopausal women. Eur J Obstet Gynecol Reprod Biol 1992;45:193-200.
31. Borduas F, Sauvageau L, Blais J, Doray G, Moreault L, Lemieux AP. Etude exploratoire des perceptions des médecins au regard du Programme québécois de dépistage du cancer du sein. Québec: Direction de la santé publique de la Régie régionale de la santé et des services sociaux de Québec. Coordination des services régionaux du Programme québécois de dépistage du cancer du sein. 2002.
32. Brown JB, Handfield-Jones R, Rainsberry P, Brailovsky CA. Certification examination of the College of Family Physicians of Canada. Part 4: Simulated office orals. Can Fam Physician 1996; 42:1539-1542,1545,1547-1548.
33. Schneider AE, Davis RB, Phillips RS. Discussion of hormone therapy between physicians and their patients. Am J Med Qual 2000;15:143-147.
34. Sarrel PM. Improving adherence to hormone therapy with effective patient-physician communication. Am J Obstet Gynecol 1999;180: S337-S3440.
35. Hunter MS, O'Dea I, Britten N. Decision-making and hormone therapy: a qualitative analysis. Soc Sci Med 1997;45:1541-1548.
36. Groupe de travail sur l'hormonothérapie de remplacement lors de la ménopause. L'hormonothérapie de remplacement à la ménopause. Guide pratique. Québec: Gouvernement du Québec, Conseil consultatif de pharmacologie. 1996.
37. Starfield B, Shi L. Policy relevant determinants of health: an international perspective. Health Policy 2002;60:201-218.
38. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomized trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). J Health Serv Res Policy 2000;5:12-16.
39. Brown AF, Perez-Stable EJ, Whitaker EE, et al. Ethnic differences in hormone replacement prescribing patterns. J Gen Intern Med 1999;14:663-669.